Dana Farber Cancer Institute Center for Sarcoma and Bone Oncology — Boston, Massachusetts

Dana Farber Cancer Institute Center for Sarcoma and Bone Oncology is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute Center for Sarcoma and Bone Oncology has participated in 1 clinical trials.

Therapeutic areas: Soft Tissue Sarcoma.

Sponsors: Threshold Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute Center for Sarcoma and Bone Oncology?

Dana Farber Cancer Institute Center for Sarcoma and Bone Oncology has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute Center for Sarcoma and Bone Oncology conducted?

Dana Farber Cancer Institute Center for Sarcoma and Bone Oncology has 1 clinical trials on record. Their work covers Soft Tissue Sarcoma.

Is Dana Farber Cancer Institute Center for Sarcoma and Bone Oncology accredited by Crixeo Clinical Trials?

Dana Farber Cancer Institute Center for Sarcoma and Bone Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute Center for Sarcoma and Bone Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.